Background: According to guidelines, behavioral and pharmacological assistance should be offered to all smokers willing to quit. However, a large proportion of ex-cigarette smokers are self-quitters. Objectives: To identify characteristics of long-term, unaided self-quitters, as compared to recurrent smokers among health care employees. Methods: University hospital employees (n = 5,218) were addressed through a 17-question questionnaire inquiring about past and current smoking behavior. Questions included daily cigarette consumption, pack-years, previous quit attempts, smoking-free period, and utilization of pharmacological therapies and counseling. Results: 2,574 (49.3%) questionnaires were returned. 791 subjects declared to have successfully quit smoking. A complete data set was available for 763 cases. Patients remained smoking free for a mean period of 11.8 ± 9.7 years. The most common smoking cessation method in these subjects was unaided (77.2%), followed by alternative approaches (15.4%), nicotine replacement therapy (4.5%), counseling (1.7%), and bupropion (1.2%). Smoking cessation was achieved with 1 attempt in 53% of the cases, 2 in 19%, 3 in 13%, and more than 3 attempts in 15%, respectively. On average, 2.4 ± 3.02 attempts led to successful smoking cessation. After 2 or more unsuccessful attempts, the odds ratio for a further unsuccessful smoking cessation was 2.58 (95% CI 1.94–3.45). Conclusion: The majority of the ex-smokers quitted smoking without any behavioral or pharmacological support. The chance to successfully quit smoking without any help in a first or second attempt is considerably high. The risk for smoking recurrence after 2 ineffective quit attempts is markedly increased (OR 2.58).

1.
World Health Organization: WHO Report on the Global Tobacco Epidemic 2013. Enforcing Bans on Tobacco Advertising, Promotion and Sponsorship. Geneva, World Health Organization, 2013.
2.
Marques-Vidal P, Cerveira J, Paccaud F, Cornuz J: Smoking trends in Switzerland, 1992–2007: a time for optimism? J Epidemiol Community Health 2011; 65: 281–286.
3.
Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238–1245.
4.
Curbing the epidemic: governments and the economics of tobacco control. The World Bank. Tob Control 1999; 8: 196–201.
5.
Molarius A, Parsons RW, Dobson AJ: Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health 2001; 91: 206–212.
6.
Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM: 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368: 351–364.
7.
World Health Organization: WHO Report on the Global Tobacco Epidemic: The MPOWER Package. Geneva, World Health Organization, 2008.
8.
Petersen PE: Tobacco and oral health: the Role of the World Health Organization. Oral Health Prev Dent 2003; 1: 309–315.
9.
Sales MP, Oliveira MI, Mattos IM, Viana CM, Pereira ED: The impact of smoking cessation on patient quality of life. J Bras Pneumol 2009; 35: 436–441.
10.
Cigarette smoking among adults – United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 51: 642–645.
11.
Jha P, Ramasundarahettige C, Landsman V, Rostrom B, Thun M, Anderson RN, McAfee T, Peto R: 21st century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368: 341–350.
12.
Wramner B: Premature mortality in lung cancer as an indicator of effectiveness of tobacco use prevention in a gender perspective-a comparison between Poland and Sweden. Cent Eur J Public Health 2001; 9: 69–73.
13.
Quitting smoking among adults – United States, 2001–2010. MMWR Morb Mortal Wkly Rep 2011; 60: 1513–1519.
14.
Thyrian JR, Panagiotakos DB, Polychronopoulos E, West R, Zatonski W, John U: The relationship between smokers’ motivation to quit and intensity of tobacco control at the population level: a comparison of five European countries. BMC Public Health 2008,8: 2.
15.
Marques-Vidal P, Melich-Cerveira J, Paccaud F, Waeber G, Vollenweider P, Cornuz J: Prevalence and factors associated with difficulty and intention to quit smoking in Switzerland. BMC Public Health 2011; 11: 227.
16.
Stolz D, Scherr A, Seiffert B, Kuster M, Meyer A, Fagerström KO, Tamm M: Predictors of success for smoking cessation at the workplace: a longitudinal study. Respiration 2014; 87: 18–25.
17.
Office of the Surgeon General (US); Office on Smoking and Health (US): The health consequences of smoking: a report of the Surgeon General. 2004. https://www.ncbi.nlm.nih.gov/pubmed/20669512.
18.
Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD: Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control 1997; 6(suppl 2):S57–S62.
19.
Fiore MC: US Public health Service Clinical Practice Guideline: treating tobacco use and dependence. Respir Care 2000; 45: 1200–1262.
20.
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014;CD000031.
21.
Lancaster T, Stead LF: Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005;CD001292.
22.
Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP: Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000; 18: 305–311.
23.
Cengelli S, O’Loughlin J, Lauzon B, Cornuz J: A systematic review of longitudinal population-based studies on the predictors of smoking cessation in adolescent and young adult smokers. Tob Control 2012; 21: 355–362.
24.
Kalkhuis-Beam S, Stevens SL, Baumritter A, Carlson EC, Pletcher JR, Rodriguez D, Audrain-McGovern J: Participant- and study-related characteristics predicting treatment completion and study retention in an adolescent smoking cessation trial. J Adolesc Health 2011; 49: 371–378.
25.
Monso E, Campbell J, Tonnesen P, Gustavsson G, Morera J: Socio-demographic predictors of success in smoking intervention. Tob Control 2001; 10: 165–169.
26.
Westmaas JL, Langsam K: Unaided smoking cessation and predictors of failure to quit in a community sample: effects of gender. Addict Behav 2005; 30: 1405–1424.
27.
Hughes JR, Keely J, Naud S: Shape of the relapse curve and long term abstinence among untreated smokers. Addiction 2004; 99: 29–38.
28.
West R, Sohal T: “Catastrophic” pathways to smoking cessation: findings from national survey. BMJ 2006; 332: 458–460.
29.
Schaap MM, Kunst AE, Leinsalu M, Regidor E, Ekholm O, Dzurova D, Helmert U, Klumbiene J, Santana P, Mackenbach JP: Effect of nationwide tobacco control policies on smoking cessation in high and low educated groups in 18 European countries. Tobacco Control 2008; 17: 248–255.
30.
Hammond D, McDonald PW, Fong GT, Borland R: Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction 2004; 99: 1042–1048.
31.
Garvey AJ, Heinold JW, Rosner B: Self-help approaches to smoking cessation: a report from the normative aging study. Addict Behav 1989; 14: 23–33.
32.
Doran CM, Valenti L, Robinson M, Britt H, Mattick RP: Smoking status of Australian general practice patients and their attempts to quit. Addict Behav 2006; 31: 758–766.
33.
Solberg LI, Asche SE, Boyle R, McCarty MC, Thoele MJ: Smoking and cessation behaviors among young adults of various educational backgrounds. Am J Public Health 2007; 97: 1421–1426.
34.
Mikkelsen SS, Dalum P, Skov-Ettrup LS, Tolstrup JS: What characterises smokers who quit without using help? A study of users and non-users of cessation support among successful ex-smokers. Tob Control 2015; 24: 556–561.
35.
Hung WT, Dunlop SM, Perez D, Cotter T: Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. BMC Public Health 2011; 11: 592.
36.
Lee CW, Kahende J: Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health 2007; 97: 1503–1509.
37.
Cokkinides VE, Ward E, Jemal A, Thun MJ: Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med 2005; 28: 119–122.
38.
Ussher M, Brown J, Rajamanoharan A, West R: How do prompts for attempts to quit smoking relate to method of quitting and quit success? Ann Behav Med 2014; 47: 358–368.
39.
Dorner TE, Tröstl A, Womastek I, Groman E: Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program. Nicotine Tob Res 2011; 13: 1068–1075.
40.
Cahill K, Moher M, Lancaster T: Workplace interventions for smoking cessation. Cochrane Database Syst Rev 2008;CD003440.
41.
Hatsukami DK, Stead LF, Gupta PC: Tobacco addiction. Lancet 2008; 371: 2027–2038.
42.
Centers for Disease Control and Prevention: Current cigarette smoking among adults –United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61: 889–894.
43.
Hughes JR, Gulliver SB, Fenwick JW, Valliere WA, Cruser K, Pepper S, Shea P, Solomon LJ, Flynn BS: Smoking cessation among self-quitters. Health Psychol 1992; 11: 331–334.
44.
Gilpin EA, Pierce JP, Farkas AJ: Duration of smoking abstinence and success in quitting. J Natl Cancer Inst 1997; 89: 572–576.
45.
Ma Y, Goins KV, Pbert L, Ockene JK: Predictors of smoking cessation in pregnancy and maintenance postpartum in low-income women. Matern Child Health J 2005; 9: 393–402.
46.
Osler M, Presscott E: Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tob Control 1998; 7: 262–267.
47.
Solomon L, Quinn V: Spontaneous quitting: self-initiated smoking cessation in early pregnancy. Nicotine Tob Res 2004(suppl 2):S203–S216.
48.
McCarthy M, Siahpush M, Shaikh RA, Sikora Kessler A, Tibbits M: Social disparities in unaided quit attempts among daily current and former smokers: results from the 2010–2011 tobacco use supplement to the current population survey. Nicotine Tob Res 2016; 18: 1705–1710.
49.
Fiore MC, Novotny TE, Pierce JP, Giovino GA, Hatziandreu EJ, Newcomb PA, Surawicz TS, Davis RM: Methods used to quit smoking in the United States. Do cessation programs help? JAMA 1990; 263: 2760–2765.
50.
Borland R, Li L, Driezen P, Wilson N, Hammond D, Thompson ME, Fong GT, Mons U, Willemsen MC, McNeill A, Thrasher JF, Cummings KM: Cessation assistance reported by smokers in 15 countries participating in the International Tabacco Control (ITC) policy evaluation surveys. Addiction 2012; 107: 197–205.
51.
Zhu WH, Yang L, Jiang CQ, Deng LZ, Lam TH, Zhang JY, Chan SS: Characteristics of smokers and predictors of quitting in a smoking cessation clinic in Guangzhou, China. J Public Health (Oxf) 2010; 32: 267–276.
52.
Gross B, Brose L, Schumann A, Ulbricht S, Meyer C, Völzke H, Rumpf HJ, John U: Reasons for not using smoking cessation aids. BMC Public Health 2008; 8: 129.
53.
Rafful C, Garcia-Rodriguez O, Wang S, Secades-Villa R, Martinez-Ortega JM, Blanco C: Predictors of quit attempts and successful quit attempts in a nationally representative sample of smokers. Addict Behav 2013; 38: 1920–1923.
54.
Vangeli E, Stapleton J, Smit ES, Borland R, West R: Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011; 106: 2110–2121.
55.
Razavi T: Self-report measures: an overview of concerns and limitations of questionnaire use in occupational stress research. https://eprints.soton.ac.uk/35712/1/01-175.pdf.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.